Removing Barriers to the Use of Systemic Agents for Patients with von Hippel-Lindau Disease

Eur Urol Oncol. 2024 Jan 24:S2588-9311(24)00027-0. doi: 10.1016/j.euo.2024.01.003. Online ahead of print.

Affiliations

¹ Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: larcher.alessandro@hsr.it.
² Department of Urology, Division of Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.

PMID: 38272746
DOI: 10.1016/j.euo.2024.01.003

No abstract available

Publication types

Letter